Table 1 Characteristics of the study population and of the current disease exacerbation
From: Efficacy and usability of a novel nebulizer targeting both upper and lower airways
rhinitis | asthma | |||
|---|---|---|---|---|
n = 39 | n = 38 | |||
Male gender, n (%) | 25 | 64 | 27 | 71 |
Age (yrs), mean (SD) | 9 | 3.0 | 10 | 3.0 |
Height (cm), mean (SD) | 139 | 17 | 143 | 18 |
Weight (kg), mean (SD) | 37 | 18 | 39 | 16 |
Atopic diseases, n (%) | ||||
Allergic rhinitis | 33 | 85 | 21 | 55 |
Allergic asthma | 24 | 62 | 31 | 82 |
Etiology, n (%)a | ||||
Viral | 24 | 62 | 11 | 29 |
Bacterial | 1 | 3 | 1 | 3 |
Allergic | 27 | 69 | 26 | 68 |
Other | 4 | 10 | 8 | 21 |
Severity, n (%) | ||||
low | 1 | 3 | 13 | 34 |
medium | 31 | 79 | 16 | 42 |
high | 4 | 10 | 7 | 18 |
very high | 3 | 8 | 2 | 5 |
Duration, n (%) | ||||
1-3 days | 4 | 10 | 21 | 55 |
4-7 days | 12 | 31 | 6 | 16 |
7-15 days | 11 | 28 | 8 | 21 |
> 15 days | 12 | 31 | 3 | 8 |
Impaiment of sleeping, n (%) | 18 | 46 | 13 | 34 |
Impairment of eating, n (%) | 0 | 0 | 3 | 8 |